Biocryst Pharmaceuticals Inc (BCRX)
EBITDA Growth
247.54%
Quarterly · Period ending:
BCRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported247.54%period ending
Latest reported247.54%period ending
BCRX Quarterly EBITDA YoY % (-107.69% → 247.54%)
Year-over-year change
High-resolution chart · PNG
BCRX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 113.4658% | |
| -3.2787% | |
| -120.4261% | |
| 27.9712% | |
| -635.3896% | |
| 5.9583% | |
| -35.2941% | |
| -199.96% | |
| 89.3793% | |
| 22.5806% | |
| 48.4848% | |
| 196.1538% | |
| -26.087% | |
| 8.8235% | |
| -65% | |
| -13.0435% | |
| -109.0909% | |
| -88.8889% | |
| 4.7619% | |
| -15% | |
| 31.25% | |
| 33.3333% | |
| -16.6667% | |
| -33.3333% | |
| 11.1111% | |
| -107.6923% |